Friend or Foe: Exploring the Relationship between the Gut Microbiota and the Pathogenesis and Treatment of Digestive Cancers
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(5), P. 955 - 955
Published: May 8, 2024
Digestive
cancers
are
among
the
leading
causes
of
cancer
death
in
world.
However,
mechanisms
development
and
progression
not
fully
understood.
Accumulating
evidence
recent
years
pointing
to
bidirectional
interactions
between
gut
dysbiosis
a
specific
type
gastrointestinal
is
shedding
light
on
importance
this
“unseen
organ”—the
microbiota.
This
review
focuses
local
role
microbiota
imbalance
different
digestive
tract
organs
annexes
related
carcinogenic
mechanisms.
Microbiota
modulation,
either
by
probiotic
administration
or
dietary
changes,
plays
an
important
future
therapies
various
cancers.
Language: Английский
Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
Siyu Wang,
No information about this author
Hua Wang,
No information about this author
Chenbei Li
No information about this author
et al.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(3)
Published: March 1, 2024
Abstract
Cancer
is
a
major
cause
of
death
globally,
and
traditional
treatments
often
have
limited
efficacy
adverse
effects.
Immunotherapy
has
shown
promise
in
various
malignancies
but
less
effective
tumors
with
low
immunogenicity
or
immunosuppressive
microenvironment,
especially
sarcomas.
Tertiary
lymphoid
structures
(TLSs)
been
associated
favorable
response
to
immunotherapy
improved
survival
cancer
patients.
However,
the
immunological
mechanisms
clinical
significance
TLS
malignant
are
not
fully
understood.
In
this
review,
we
elucidate
composition,
neogenesis,
immune
characteristics
tumors,
as
well
inflammatory
development.
An
in‐depth
discussion
unique
TLSs
lung
cancer,
breast
melanoma,
soft
tissue
sarcomas
will
be
presented.
Additionally,
therapeutic
implications
TLS,
including
its
role
marker
prognosis,
strategies
promote
formation
maturation
explored.
Overall,
aim
provide
comprehensive
understanding
tumor
microenvironment
suggest
potential
interventions
for
treatment.
Language: Английский
Roles of tertiary lymphatic structures in gastric cancer
Xudong Yan,
No information about this author
Ling-Ling Fan,
No information about this author
Weimin Wang
No information about this author
et al.
Shijie huaren xiaohua zazhi,
Journal Year:
2025,
Volume and Issue:
33(3), P. 178 - 182
Published: March 28, 2025
Language: Английский
Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma
Xinyu Su,
No information about this author
Donglin Kang,
No information about this author
Jiayu Wang
No information about this author
et al.
npj Precision Oncology,
Journal Year:
2025,
Volume and Issue:
9(1)
Published: April 9, 2025
Understanding
the
impact
of
tertiary
lymphoid
structures
(TLSs)
on
acral
melanoma
(AM)
and
tumor
microenvironment
(TME)
is
critical.
We
analyzed
TLS
features
in
primary
AM
lesions
from
46
patients
identified
intratumoral
TLSs
(intra-TLSs)
25
patients.
Intra-TLS
presence
was
significantly
associated
with
improved
overall
survival.
Hematoxylin
eosin
staining
multiplex
immunofluorescence
revealed
increased
T-cell
CD8+
infiltration
fewer
tumor-associated
macrophages
TME
intra-TLS
Transcriptomic
analysis
a
TLS-associated
Th1/B-cell
gene
set
as
predictor
survival
immunotherapy
response.
These
findings
highlight
prognostic
value
intra-TLSs
AMs
suggest
that
targeting
formation
could
enhance
efficacy.
Language: Английский
Cell of origin alters myeloid-mediated immunosuppression in lung adenocarcinoma
Minxiao Yang,
No information about this author
Noah Shulkin,
No information about this author
Edgar R. Gonzalez
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 23, 2024
Solid
carcinomas
are
often
highly
heterogenous
cancers,
arising
from
multiple
epithelial
cells
of
origin.
Yet,
how
the
cell
origin
influences
response
tumor
microenvironment
is
poorly
understood.
Lung
adenocarcinoma
(LUAD)
arises
in
distal
alveolar
epithelium
which
populated
primarily
by
type
I
(AT1)
and
II
(AT2)
cells.
It
has
been
previously
reported
that
Language: Английский